Content about Symphony Health Solutions

April 2, 2014

Symphony Health Solutions on Wednesday released research on the affects of the Affordable Care Act on Medicaid drug spending.

HORSHAM, Pa. — Symphony Health Solutions on Wednesday released research on the affects of the Affordable Care Act on Medicaid drug spending.

The research found that prescription claims for Medicaid patients increased in January by 10% and in February by 14% over the same periods last year. The study also uncovered that average out-of-pocket cost for contraceptives has dropped more than 58% since 2012.

November 26, 2013

The number of patients receiving prescriptions for statins is expected to increase modestly following new cholesterol recommendations from the American College of Cardiology and the American Heart Association, according to a new report.

SAN MATEO, Calif. – The number of patients receiving prescriptions for statins is expected to increase modestly following new cholesterol recommendations from the American College of Cardiology and the American Heart Association, according to a new report.

May 29, 2013

The Food and Drug Administration has approved a generic drug for incontinence made by Perrigo Co., the drug maker said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic drug for incontinence made by Perrigo Co., the drug maker said Wednesday.

Perrigo announced the approval of trospium chloride extended-release capsules in the 60 mg strength, a once-daily treatment for overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency. The drug is a generic version of Allergan's Sanctura XR, which has annual sales of $54 million, according to Symphony Health Solutions.

January 15, 2013

Symphony Health Solutions named Frank Lavelle CEO.

HORSHAM, Pa. — Symphony Health Solutions on Tuesday named Frank Lavelle CEO.  

August 30, 2012

Symphony Health Solutions has expanded its senior leadership team.

HORSHAM, Pa. — Symphony Health Solutions has expanded its senior leadership team.

The company — which is owned by Palo Alto, Calif.-based strategic equity firm Symphony Technology Group — said former SunGuard Higher Education CFO John Milana has been appointed CFO of the company;  Jonathan Rosan, who had served as general counsel for interactive marketing agency Rosetta, has been named general counsel; and software engineering veteran Nigel Pratt has been named chief technology officer.